Fisher & Paykel Healthcare Corporation Limited Share Price OTC Markets

Equities

FSPKF

NZFAPE0001S2

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 07:00:02 22/04/2024 pm IST 5-day change 1st Jan Change
16.14 USD +3.20% Intraday chart for Fisher & Paykel Healthcare Corporation Limited -.--% +14.39%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 1.73B 1.05B 87.72B Sales 2025 * 1.94B 1.18B 98.33B Capitalization 16.82B 10.2B 851B
Net income 2024 * 257M 156M 13.01B Net income 2025 * 331M 201M 16.75B EV / Sales 2024 * 9.81 x
Net Debt 2024 * 179M 109M 9.08B Net Debt 2025 * 235M 142M 11.89B EV / Sales 2025 * 8.78 x
P/E ratio 2024 *
65.2 x
P/E ratio 2025 *
50.3 x
Employees 6,420
Yield 2024 *
1.37%
Yield 2025 *
1.49%
Free-Float 91.12%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Fisher & Paykel Healthcare Corporation Limited

1 day+3.20%
1 month+3.20%
3 months+10.78%
6 months+28.61%
Current year+14.39%
More quotes
1 month
16.14
Extreme 16.14
16.14
Current year
14.00
Extreme 14
16.14
1 year
12.00
Extreme 12
16.39
3 years
10.24
Extreme 10.24
24.06
5 years
9.71
Extreme 9.71
26.46
10 years
3.74
Extreme 3.74
26.46
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 01/85/01
Director of Finance/CFO - 01/19/01
Chief Tech/Sci/R&D Officer - 01/07/01
Members of the board TitleAgeSince
Director/Board Member 66 01/90/01
Chairman - 01/15/01
Chief Executive Officer 63 01/85/01
More insiders
Date Price Change Volume

Delayed Quote OTC Markets, April 22, 2024 at 07:00 pm IST

More quotes
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The Company provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. It operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India and others.
Calendar
Related indices
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
28.8 NZD
Average target price
24.49 NZD
Spread / Average Target
-14.98%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW